Exponent, Inc. (NASDAQ:EXPO) is Geneva Capital Management LLC’s 4th Largest Position

Geneva Capital Management LLC boosted its stake in Exponent, Inc. (NASDAQ:EXPO) by 10.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,558,189 shares of the business services provider’s stock after acquiring an additional 146,778 shares during the period. Exponent accounts for 2.6% of Geneva Capital Management LLC’s portfolio, making the stock its 4th largest position. Geneva Capital Management LLC owned approximately 3.08% of Exponent worth $137,183,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently added to or reduced their stakes in the company. Operose Advisors LLC bought a new stake in Exponent during the third quarter valued at $39,000. Signaturefd LLC grew its holdings in shares of Exponent by 157.7% during the third quarter. Signaturefd LLC now owns 915 shares of the business services provider’s stock valued at $78,000 after purchasing an additional 560 shares during the last quarter. Parkside Financial Bank & Trust raised its position in shares of Exponent by 10.5% during the 3rd quarter. Parkside Financial Bank & Trust now owns 1,468 shares of the business services provider’s stock worth $126,000 after purchasing an additional 140 shares during the period. Covestor Ltd boosted its position in Exponent by 24.8% during the 3rd quarter. Covestor Ltd now owns 1,474 shares of the business services provider’s stock valued at $126,000 after purchasing an additional 293 shares during the period. Finally, Quadrature Capital Ltd increased its position in Exponent by 6.7% in the third quarter. Quadrature Capital Ltd now owns 2,452 shares of the business services provider’s stock worth $210,000 after buying an additional 155 shares during the period. 92.37% of the stock is owned by institutional investors and hedge funds.

Exponent Price Performance

Shares of EXPO stock traded up $0.41 on Thursday, reaching $94.46. 279,375 shares of the stock were exchanged, compared to its average volume of 310,985. The stock has a 50 day moving average price of $82.39 and a 200 day moving average price of $82.15. The stock has a market cap of $4.78 billion, a PE ratio of 47.71 and a beta of 0.64. Exponent, Inc. has a one year low of $64.61 and a one year high of $102.72.

Exponent (NASDAQ:EXPO) last released its quarterly earnings data on Thursday, April 25th. The business services provider reported $0.59 EPS for the quarter, beating analysts’ consensus estimates of $0.46 by $0.13. The business had revenue of $137.21 million during the quarter, compared to the consensus estimate of $125.98 million. Exponent had a return on equity of 28.13% and a net margin of 18.72%. The firm’s revenue was up 6.6% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.56 earnings per share. On average, research analysts expect that Exponent, Inc. will post 1.92 earnings per share for the current fiscal year.

Exponent Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 21st. Shareholders of record on Friday, June 7th will be paid a $0.28 dividend. The ex-dividend date is Friday, June 7th. This represents a $1.12 dividend on an annualized basis and a yield of 1.19%. Exponent’s payout ratio is 56.57%.

Analysts Set New Price Targets

Several research firms have recently issued reports on EXPO. Truist Financial increased their price target on Exponent from $95.00 to $100.00 and gave the stock a “buy” rating in a research note on Monday, April 29th. StockNews.com raised Exponent from a “sell” rating to a “hold” rating in a report on Monday, March 4th.

Insider Buying and Selling at Exponent

In other Exponent news, VP Bradley A. James sold 3,528 shares of the firm’s stock in a transaction that occurred on Monday, May 6th. The shares were sold at an average price of $95.00, for a total transaction of $335,160.00. Following the sale, the vice president now directly owns 2,030 shares in the company, valued at approximately $192,850. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other news, VP Bradley A. James sold 3,528 shares of the company’s stock in a transaction dated Monday, May 6th. The stock was sold at an average price of $95.00, for a total transaction of $335,160.00. Following the completion of the transaction, the vice president now directly owns 2,030 shares of the company’s stock, valued at $192,850. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Eric Guyer sold 1,650 shares of the company’s stock in a transaction that occurred on Tuesday, April 30th. The stock was sold at an average price of $92.58, for a total value of $152,757.00. Following the transaction, the insider now directly owns 1,846 shares of the company’s stock, valued at approximately $170,902.68. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 8,558 shares of company stock valued at $753,402. Company insiders own 2.20% of the company’s stock.

Exponent Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.